Open AccessMethylation ofIRAK3is a novel prognostic marker in hepatocellular carcinoma
Author(s) -
Chih-Chi Kuo,
YuLueng Shih,
HerYoung Su,
MingDe Yan,
Hsieh Cc,
Chin-Yu Liu,
Weiting Huang,
Mu-Hsien Yu,
Ya-Wen Lin
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i13.3960
Subject(s) - methylation , hepatocellular carcinoma , dna methylation , cancer research , biology , methyltransferase , microbiology and biotechnology , polymerase chain reaction , cpg site , gene , gene expression , genetics
To examine the methylation levels of interleukin-1 receptor-associated kinase 3 (IRAK3) and GLOXD1 and their potential clinical applications in hepatocellular carcinoma (HCC).